Personalized mRNA cancer vaccines are showing early success in clinical trials, fueling optimism in the fight against cancer.

What you’ll discover in this article ・tRNA-based treatments are a promising approach for genetic diseases caused by nonsense ...

A consistent biological barrier that stops the immune system from making the antibodies most needed to protect the nose and throat from respiratory viruses has been identified. The discovery, led by ...

A pizza shop with 30 delivery people ought to be able to deliver a lot of pizzas - if their cars don't break down on the way. Likewise, genes that produce a lot of messenger RNA (mRNA) molecules can ...

CBS News medical correspondent Dr. Céline Gounder, who has had melanoma herself, said Moderna's experimental trial is "a big win for mRNA vaccines against cancer." ...

The central dogma of biology defines the flow of genetic information: It describes how proteins are made from mRNA templates, which are in turn made from DNA. Exporting the mRNA from inside the ...

HPV mRNA E6/E7 indicates the presence of high risk HPV strains that can potentially lead to cancer. These strains instruct cells to produce proteins that may transform them into cancerous cells.

While mRNA may be back in the headlines courtesy of Moderna and Merck & Co.'s phase 3 cancer vaccine success, new research ...

A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of the first made with the same mRNA technology that was key to ending the ...

The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.